Intralesional Injection of STS in Treatment of Calcinosis (NCT06672822)
An Open Label Evaluation of Intralesional Injection of Sodium Thiosulfate in the Treatment of Cutaneous or Tendon Calcinosis in Connective Tissue Disease
🩺 Plain-English Summary (8th-Grade Level)
The specific objective of this study is to perform a small, open-label study to assess the safety and efficacy of intralesional, subcutaneous injection of STS on calcinosis symptoms and lesion size in systemic sclerosis (SSc), mixed connective tissue disease (MCTD) and dermatomyositis (DM) patients. Injection will be guided by ultrasound, lesion size assessed by ultrasound, and symptom burden by patient-reported outcome measures.
Who can join: Review the eligibility criteria below.
Location: UPMC Arthritis and Autoimmunity Center — Pittsburgh, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UPMC Arthritis and Autoimmunity Center — Pittsburgh, Pennsylvania
📞 Contact the Study Coordinator
Phone: (412) 648-7874
Email: laffoonm@pitt.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Systemic Sclerosis (SSc)
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) — La Jolla, California
- Mycophenolate After Stem Cell Transplant for Systemic Sclerosis — Ottawa, Ontario
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Phoenix, Arizona
- Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images — New Haven, Connecticut
- Systemic Sclerosis DIet for GastrointESTinal Symptoms — Ann Arbor, Michigan
Explore by condition: All Systemic Sclerosis (SSc) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.